IP Library › Assignment 042310/0619
Patent Assignment
Reel/Frame 042310/0619

General Conveyance and Assumption Agreement

Recorded: 2017-04-21 Pages: 5
Assignor
RVX THERAPEUTICS INC.
Executed: 2014-05-01
Assignee
ZENITH EPIGENETICS CORP.
300,4820 RICHARD ROAD SW, CALGARY, AB, T3E 6L1, CANADA
Covered Property (1)
Novel Bicyclic Bromodomain Inhibitors
Application: 15/486,256 →
Publication: US 2017/0216301
Related Assignments (4)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Apr 20, 2017
From: QUINN, JOHN FREDERICK; DUFFY, BRYAN CORDELL; LIU, SHUANG; WANG, RUIFANG
To: RVX THERAPEUTICS INC.
Reel/Frame 042285/0747 →
Assignment of Assignor's Interest Apr 20, 2017
From: QUINN, JOHN FREDERICK; DUFFY, BRYAN CORDELL; LIU, SHUANG; WANG, RUIFANG
To: ZENITH EPIGENETICS CORP.
Reel/Frame 042285/0768 →
Assignment of Assignor's Interest Apr 21, 2017
From: ZENITH CAPITAL CORP.
To: ZENITH EPIGENETICS LTD.
Reel/Frame 042092/0756 →
Change of Name Apr 21, 2017
From: ZENITH EPIGENETICS CORP.
To: ZENITH CAPITAL CORP.
Reel/Frame 042310/0644 →